|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C32.9 |
Malignant neoplasm of larynx, unspecified
|
C329 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.07%
|
23.75%
|
10.16%
|
5.54%
|
2.72%
|
1.99%
|
1.12%
|
0.75%
|
0.55%
|
0.34%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C32.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
8,805
|
8,889
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
4,327
|
4,331
|
|
80053
|
COMPREHEN METABOLIC PANEL |
4,124
|
4,124
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,933
|
3,953
|
|
77386
|
NTSTY MODUL RAD TX DLVR CPLX |
3,333
|
3,341
|
|
31575
|
DIAGNOSTIC LARYNGOSCOPY |
2,413
|
2,416
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
2,074
|
196,050
|
|
83735
|
ASSAY OF MAGNESIUM |
1,843
|
1,850
|
|
84443
|
ASSAY THYROID STIM HORMONE |
1,692
|
1,697
|
|
70491
|
CT SOFT TISSUE NECK W/DYE |
1,682
|
1,682
|
|
71260
|
CT THORAX DX C+ |
1,212
|
1,212
|
|
92526
|
ORAL FUNCTION THERAPY |
1,190
|
1,190
|
|
97110
|
THERAPEUTIC EXERCISES |
1,126
|
1,900
|
|
97530
|
THERAPEUTIC ACTIVITIES |
1,107
|
1,798
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,031
|
1,031
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
1,030
|
1,030
|
|
G1004
|
CDSM NDSC |
1,009
|
1,179
|
|
92507
|
TX SP LANG VOICE COMM INDIV |
995
|
998
|
|
82565
|
ASSAY OF CREATININE |
955
|
957
|
|
92597
|
ORAL SPEECH DEVICE EVAL |
943
|
943
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C32.9 related to the following DRG Codes:
011-013
146-148
|
